Your browser doesn't support javascript.
loading
ALK positively regulates MYCN activity through repression of HBP1 expression.
Claeys, Shana; Denecker, Geertrui; Durinck, Kaat; Decaesteker, Bieke; Mus, Liselot M; Loontiens, Siebe; Vanhauwaert, Suzanne; Althoff, Kristina; Wigerup, Caroline; Bexell, Daniel; Dolman, Emmy; Henrich, Kai-Oliver; Wehrmann, Lea; Westerhout, Ellen M; Demoulin, Jean-Baptiste; Kumps, Candy; Van Maerken, Tom; Laureys, Genevieve; Van Neste, Christophe; De Wilde, Bram; De Wever, Olivier; Westermann, Frank; Versteeg, Rogier; Molenaar, Jan J; Påhlman, Sven; Schulte, Johannes H; De Preter, Katleen; Speleman, Frank.
Afiliação
  • Claeys S; Center for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
  • Denecker G; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Durinck K; Center for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
  • Decaesteker B; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Mus LM; Center for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
  • Loontiens S; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Vanhauwaert S; Center for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
  • Althoff K; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Wigerup C; Center for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
  • Bexell D; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Dolman E; Center for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
  • Henrich KO; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Wehrmann L; Center for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
  • Westerhout EM; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Demoulin JB; Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany.
  • Kumps C; Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund University, Lund, Sweden.
  • Van Maerken T; Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund University, Lund, Sweden.
  • Laureys G; Princess Maxima Center for Pediatric Cancer, Utrecht, The Netherlands.
  • Van Neste C; Neuroblastoma Genomics B087, German Cancer Research Center, Heidelberg, Germany.
  • De Wilde B; Neuroblastoma Genomics B087, German Cancer Research Center, Heidelberg, Germany.
  • De Wever O; Department of Oncogenomics, Academic Medical Center, Amsterdam, The Netherlands.
  • Westermann F; De Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
  • Versteeg R; Center for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
  • Molenaar JJ; Department of Uro-Gynaecology, Ghent University Hospital, Ghent, Belgium.
  • Påhlman S; Center for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
  • Schulte JH; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • De Preter K; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Speleman F; Department of Pediatric Oncology and Hematology, Ghent University Hospital, Ghent, Belgium.
Oncogene ; 38(15): 2690-2705, 2019 04.
Article em En | MEDLINE | ID: mdl-30538293
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Proteínas de Grupo de Alta Mobilidade / Proteína Proto-Oncogênica N-Myc / Quinase do Linfoma Anaplásico / Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Oncogene Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Proteínas de Grupo de Alta Mobilidade / Proteína Proto-Oncogênica N-Myc / Quinase do Linfoma Anaplásico / Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Oncogene Ano de publicação: 2019 Tipo de documento: Article